Acumen Pharmaceuticals (ABOS) Change in Account Payables (2020 - 2026)
Acumen Pharmaceuticals recorded quarterly Change in Account Payables of $1.0 million in Q1 2026, up 917.97% quarter-over-quarter from -$128000.0 in Q4 2025, and up 122.8% year-over-year from $469927.1 in Q1 2025.
Acumen Pharmaceuticals' Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 122.8% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $545000.0 (up 126.94% YoY), while the FY2025 annual figure was -$5.1 million, down 219.33% from the prior year.
- Change in Account Payables came in at $1.0 million for Q1 2026 at Acumen Pharmaceuticals, up from -$128000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.3 million in Q4 2024 to a low of -$4.6 million in Q1 2025.
- A 5-year average of $30176.5 and a median of $121000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables plunged 825.62% in 2023 and surged 19347.06% in 2024, its largest moves.
- Acumen Pharmaceuticals' Change in Account Payables stood at -$444000.0 in 2022, then soared by 103.83% to $17000.0 in 2023, then soared by 19347.06% to $3.3 million in 2024, then sank by 103.87% to -$128000.0 in 2025, then soared by 917.97% to $1.0 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.0 million, -$128000.0, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | -128,000.00 |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | -1.42 Mn |
| Sep 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | -4.59 Mn |
| Mar 31, 2025 | -4.59 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | -662,000.00 |
| Sep 30, 2023 | -662,000.00 |
| Jun 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | -878,000.00 |
| Mar 31, 2023 | -878,000.00 |
| Dec 31, 2022 | -444,000.00 |
| Dec 31, 2022 | -444,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 121,000.00 |
| Mar 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 706,000.00 |
| Dec 31, 2021 | 706,000.00 |
| Sep 30, 2021 | -890,000.00 |
| Sep 30, 2021 | -890,000.00 |
| Jun 30, 2021 | 354,000.00 |
| Jun 30, 2021 | 354,000.00 |
| Mar 31, 2021 | 387,000.00 |
| Mar 31, 2021 | 387,000.00 |
| Dec 31, 2020 | -923,000.00 |
| Dec 31, 2020 | -923,000.00 |
| Sep 30, 2020 | 851,000.00 |
| Sep 30, 2020 | 851,000.00 |